Saltar al contenido
Black Friday — 30% OFFEnvío gratis en pedidos desde 99 €
  1. Inicio
  2. Salud cognitiva y nootrópicos
  3. Noopept (Omberacetam), (30mg/capsule), 60 Capsules
Salud cognitiva

Noopept (Omberacetam), (30mg/capsule), 60 Capsules

Noopept (Omberacetam) is a synthetic dipeptide analog of the racetam family, known for its role in glutamatergic and cholinergic signaling pathways.

Presentación: Noopept (Omberacetam), (30mg/capsule), 60 Capsules.

Envase ilustrativo generado con IA.

El precio original era: 24,99 €.El precio actual es: 17,49 €.

No disponible actualmente en España

Consulta a un asesor
Un asesor se pone en contacto contigo y la farmacia asociada comprueba si es posible continuar y cómo. Puede ser necesaria una receta válida o una evaluación a través de un servicio de telemedicina autorizado.
  • Farmacia asociada
  • Atención personalizada
  • Entrega discreta
  • Presentación
    Noopept (Omberacetam), (30mg/capsule), 60 Capsules

Envío y entrega

  • Envío habitual en 24 horas tras confirmarse el pago.
  • USPS Regular Shipping · 11,95 € · Aprox. 3–5 días laborables
  • FedEx 2 Days Delivery · 28,99 € · Aprox. 2 días laborables
  • FedEx Overnight Delivery · 40,99 € · Aprox. 1 día laborable

Solo para investigación de laboratorio.

No apto para uso humano o veterinario.

Composición y detalles del producto

Descripción

Noopept (Omberacetam) is a synthetic dipeptide analog of the racetam family, known for its role in glutamatergic and cholinergic signaling pathways. It exhibits high affinity for AMPA and NMDA receptors, contributing to its involvement in synaptic transmission and neurochemical interactions.

This compound undergoes rapid hydrolysis into bioactive peptide fragments, facilitating its metabolic activity. Noopept is processed through hepatic oxidation and conjugation, with primary clearance occurring via renal excretion.

  • High Purity – 99% Purity Guaranteed
  • Independently Lab Tested
  • Research Grade Quality
  • For Laboratory Research Use Only

Propiedades

Noopept (ethyl 1-(phenylacetyl)-L-prolylglycinate) is a synthetic dipeptide-derived small molecule and prodrug of cycloprolylglycine (cPG), an endogenous cyclic peptide. Following biotransformation, it yields cycloprolylglycine, a metabolite investigated for its interactions with glutamatergic signaling systems, including AMPA- and NMDA receptor-associated pathways. Experimental studies have also examined Noopept’s interactions with peptide-mediated regulatory mechanisms, receptor-associated signaling networks, and molecular communication pathways involved in signal transduction. Additional investigations have explored its effects on protein interaction systems, transcriptional regulation processes, and small molecule–peptide pharmacology. Research applications include AMPA/NMDA receptor pharmacology, glutamatergic signaling investigation, prodrug metabolism studies, cycloprolylglycine-related research, and mechanistic evaluation of receptor-associated regulatory systems. Supplied in 30 mg capsules. Independently third-party HPLC-tested; COA available per batch.

Investigación

HPLC Noopept Caps (6739 / M26AYNoo)
September 11, 2026

HPLC Noopept Caps (6739)
August 7, 2026

Los excipientes de la cápsula no se especifican en la documentación disponible.